Document Detail


Hypereosinophilic syndrome in childhood: clinical and molecular features of two cases.
MedLine Citation:
PMID:  19382034     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hypereosinophilic syndrome (HES) represents a heterogeneous group of diseases, some of which are being clarified by recent advances in molecular genetics. It is very rare in children. Uncertainties in classification and lack of prospective studies make therapeutic decisions difficult. The authors report two cases of HES in which steroid therapy was effective.
Authors:
Piero Farruggia; Paolo D'Angelo; Antonio Acquaviva; Antonino Trizzino; Fabio Tucci; Daniela Cilloni; Francesca Messa; Alfonso D'Ambrosio; Maurizio Aricò
Related Documents :
15573654 - "moebius syndrome": a case report.
7471624 - The clinical and radiological features of the empty sella syndrome.
4052714 - The spectrum of the oro-facial digital syndrome.
20951904 - Ulnar impaction.
16305844 - Tracheal compression caused by straight back syndrome, chest wall deformity, and anteri...
8173834 - Tourette's syndrome in new zealand. a postal survey.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Pediatric hematology and oncology     Volume:  26     ISSN:  1521-0669     ISO Abbreviation:  Pediatr Hematol Oncol     Publication Date:    2009 Apr-May
Date Detail:
Created Date:  2009-04-21     Completed Date:  2009-06-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8700164     Medline TA:  Pediatr Hematol Oncol     Country:  England    
Other Details:
Languages:  eng     Pagination:  129-35     Citation Subset:  IM    
Affiliation:
Pediatric Hematology & Oncology, G. Di Cristina Children's Hospital, Palermo, Italy. farruggia.oep@ospedalecivicopa.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bone Marrow Examination
Child
Cytogenetic Analysis
Humans
Hypereosinophilic Syndrome / diagnosis*,  drug therapy*
Male
Prednisone / therapeutic use
Steroids / therapeutic use
Treatment Outcome
Chemical
Reg. No./Substance:
0/Steroids; 53-03-2/Prednisone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Haploidentical hematopoietic stem cell transplantation in child hematologic malignancies with G-CSF-...
Next Document:  The case of a 1-year-old girl with hereditary hyperferritinemia cataract syndrome.